Skip to main content
Diagnos Inc logo

Diagnos Inc — Investor Relations & Filings

Ticker · ADK ISIN · CA2524423068 LEI · 254900ZF529VWZDVUS82 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 697 across all filing types
Latest filing 2022-09-06 Regulatory Filings
Country CA Canada
Listing TSXV ADK

About Diagnos Inc

https://www.diagnos.com/

Diagnos Inc. is a technology company specializing in software-based services for the healthcare sector, focusing on the early detection of critical health problems. The company leverages its proprietary FLAIRE Artificial Intelligence (AI) platform, which combines contextual imaging and data analysis to develop algorithms, process images, and analyze data. A primary application of this technology is AI retina analysis for screening and monitoring diseases, such as diabetes, to prevent vision loss. Diagnos aims to enable digital transformation in healthcare by providing cost-effective early detection solutions to primary care facilities and specialists across international markets, including North America and Latin America.

Recent filings

Filing Released Lang Actions
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is a Form 45-106F1 Report of Exempt Distribution, which is a regulatory filing used to report distributions of securities under exemptions from prospectus requirements in Canada. It includes detailed information about the issuer, the distribution, securities involved, purchaser information, and compensation related to the distribution. The form is a regulatory compliance document rather than a financial report, earnings release, or management discussion. It does not contain financial statements or management analysis but is a formal regulatory disclosure. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length (15,000 characters) and detailed form content confirm it is not a brief announcement or a report publication announcement.
2022-09-06 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a FORM 51-102F3 Material Change Report filed under National Instrument 51-102. It details a private placement financing transaction, including the issuance of convertible debentures and warrants, proceeds usage, and related party participation. The document is a regulatory filing reporting a material change event, specifically a financing update, but it is not a full financial report or earnings release. Given the detailed description of the financing event and the nature of the document as a material change report, it fits best under Capital/Financing Update (CAP). The document length is 3393 characters, which is consistent with a detailed announcement rather than a brief notice or a full annual/interim report. Therefore, the classification is CAP with high confidence.
2022-09-01 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of a private placement financing by DIAGNOS Inc. It details the terms of the private placement, including the issuance of convertible debentures and warrants, the use of proceeds, and related party participation. There is no indication that this is a full financial report, audit, or earnings release. The content focuses on capital raising activities and financing terms. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is 4777 characters, which is consistent with a detailed announcement rather than a brief notice or a full report.
2022-09-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate. It is a certification by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2022. The document does not contain the actual interim financial statements or substantive financial data but is a certification letter related to the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3094 characters), and it is clearly a certification rather than the report itself.
2022-08-25 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate. It is a certification letter by the CFO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2022. The document does not contain actual financial statements or substantive financial data but is an officer certification related to interim filings. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3114 characters), and it is clearly a certification letter, not the interim report or MD&A itself.
2022-08-25 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-08-25 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.